Shorts

2:07
What’s Ahead for Movement Disorder Care in 2026
8 months ago
by
Kathrin LaFaver, MD, FAAN, DipABLM(+1 more)

1:33
Investigating the Mechanisms of PIRA Using In Vitro Models
8 months ago
by
Valentina Fossati, PhD(+1 more)

1:24
Understanding the Link Between EBV and MS
8 months ago
by
Micah Luftig(+1 more)

1:33
Unearthing Whether MS Onset Occurs Before EBV Infection
8 months ago
by
Dalia Rotstein, MD, MPH(+1 more)

1:33
ACTRIMS 2026: Clinical Perspectives
8 months ago
by
Daniel Ontaneda, MD, PhD(+1 more)

1:02
Exploring the Mechanisms of Bazedoxifene Acetate (BZA)
8 months ago
by
Riley Bove, MD(+1 more)

2:04
Building Pediatric Neurology Rapport Through Spanish
8 months ago
by
Swathi Tata (+1 more)

1:22
Neurological Exam in Spanish for Culturally Competent Care
8 months ago
by
Anne Francine Pino(+1 more)

2:08
Mentoring to Expand the Child Neurology Workforce
8 months ago
by
Adam Wallace, MD(+1 more)

2:06
Building the Child Neurology Workforce Earlier in Training
8 months ago
by
John Pugh, MD, PhD(+1 more)

1:29
Improving Equitable Care Access in Child Neurology
8 months ago
by
Jordan Cole, MD(+1 more)

1:34
Responsible and Inclusive Clinical Research Practices
8 months ago
by
Jennifer Yang, MD(+1 more)

1:30
Representation in Pediatric Neurology Research
8 months ago
by
Senyene Hunter, MD, PhD(+1 more)

1:18
Integrating Social Determinants of Health in Research
8 months ago
by
Marisela Dy-Hollins, MD (+1 more)

1:31
Using Qualitative Research to Amplify Community Voices
8 months ago
by
Laura Kirkpatrick, MD(+1 more)

1:21
Evolution of Antiamyloid Therapies in Alzheimer Disease
8 months ago
by
Robert Alexander, MD(+1 more)

1:13
Emerging Therapies in Neuromuscular Disorders
8 months ago
by
Amit Sachdev, MD, MS(+1 more)

1:08
Integrating AI and Translational Science to Advance ALS Care
8 months ago
by
Crystal Yeo, MD, PhD(+1 more)

1:53
Envisioning the Future of Epilepsy Care for Patients With Depressive Symptoms
8 months ago
by
Cortney Wolfe-Christensen, PhD(+2 more)

1:10
At-Home Autoinjector of Lecanemab for Alzheimer Disease
8 months ago
by
Robert Przybelski, MD, MS (+1 more)

1:34
Advancements in Alzheimer Disease Biomarkers
8 months ago
by
Nicholas Ashton, PhD(+1 more)

1:28
Lessons on Strong Recruitment From the U.S. POINTER Study
8 months ago
by
Jessica Langbaum, PhD(+1 more)

1:21
Biomarker Use and Targeted Treatments in Alzheimer Disease
8 months ago
by
Aaron Burstein, PharmD(+1 more)

1:08
Using Digital Tools to Shift Azheimer Detection Upstream
8 months ago
by
John Showalter, MD, MSIS (+1 more)

1:28
Pioneering Alzheimer Disease Neuroimaging and Neuropathology
8 months ago
by
Takeshi Iwatsubo, MD, PhD(+1 more)

1:03
Seronegative NMOSD in New Diagnostic Criteria
8 months ago
by
Álvaro Cobo-Calvo, MD, PhD(+1 more)

1:07
The Role of Virtual Reality in MS Rehabilitation
9 months ago
by
Tobias Nef, PhD(+1 more)

0:53
Previewing 2026 MDA Conference
9 months ago
by
Angela Lek, PhD(+1 more)

1:02
Rituximab Shows Promise as Long-Term Treatment for Relapsing MS
9 months ago
by
Louie Pasculli(+1 more)

1:20
Enhancing ALS Care Through Clinical Trial Readiness
9 months ago
by
Brian Lin, PhD(+1 more)
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Approves Tavapadon for the Treatment of Parkinson Disease
2
FDA Accepts Fenebrutinib NDA Under Priority Review for Relapsing and Primary Progressive MS
3
ADHERE REAL Study to Assess Real-World Effectiveness of Efgartigimod in CIDP
4
Phase 4 OCTAGON Trial to Test Rapid Steroid Taper With Ravulizumab
5
